26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning in...
Hence then, the article about ucb presents latest research and clinical advancement across leading epilepsy portfolio at international epilepsy congress was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress )
Also on site :
- Welcome to the mega-war: Mideast and European conflicts merge, sucking in more countries along the way—even ones claiming neutrality
- Total eclipse, shooting stars, and the Milky Way: Why Aug. 12 could be the greatest single day and night for skywatching for years
- “Alguien va a morir”: la incitación contra los periodistas preocupa en Israel a medida que se acercan las elecciones